Inaugural Director, BRCA Center
Los Angeles, California
This is an exciting opportunity to establish a new BRCA Center at Cedars-Sinai and develop the reputation of the organization as the premier BRCA Center in the United States. The Director will have significant resources to build the highest quality academic medical and research BRCA Center, including the recruitment of new talent and the support of existing talent. In addition to institutional startup, The BRCA Center Director will be administratively supported to continue the growth of the center through philanthropic, foundation and federal funding opportunities.
Serving as the “face” of the Center in professional forums, the Director of the BRCA Center reports to the Director of Cedars-Sinai Cancer, Dan Theodorescu, MD, PhD, and will oversee all academic, research, clinical, operational, fundraising, and business development activities of the BRCA Center in partnership with academic, hospital and medical network leadership.
The Ideal Candidate will be a collaborative leader and partner, able to shape an environment for creative, entrepreneurial scientific investigation and clinical implementation. Providing overall executive direction for all BRCA related research and clinical programs in conjunction with the relevant Department Chairs, Institute Directors, and scientific and medical Staff, the Director’s attributes will include:
• National scientific leadership in a BRCA research field,
• Track record of peer reviewed extramural funding in a BRCA research field,
• Current federal research funding in a BRCA research field; and
• MD, MD/PhD, PhD, or equivalent
Ranked by US News & World Report as the #9 Best Hospital in Cancer Nationally in 2021-2022, the Cedars-Sinai Cancer program sees more than 5200 new cases of cancer per year and is part of the Cedars-Sinai health system, a rapidly expanding vertically integrated health system with practices located in Southern California.
Cedars-Sinai Cancer has innumerable providers across the Cedars-Sinai health system who are knowledgeable and experienced in the management of patients with BRCA mutations. The BRCA Center’s clinical objectives are twofold: 1) aligning all clinical services throughout the Cedars-Sinai health system within Cedars-Sinai Cancer so that patients with BRCA mutations receive optimal personalized care; and 2) offering patients the opportunity to participate in clinical trials that provide them access to promising novel therapies and potentially helping others with similar cancers. This approach demonstrates Cedars-Sinai Cancer’s commitment to translating discoveries from research conducted from laboratory bench to a patient’s bedside. The aspiration is for research to enable Cedars-Sinai to understand which patient’s genetic signatures are associated with sufficient risk to warrant intervention and which cancers respond to which agents. This is exemplified best across all cancer types in the recently unveiled Molecular Twin Precision Cancer Initiative which can be leveraged by all cancer researchers including those working on BRCA.
Nominations are greatly appreciated and may be sent to:
Bernard Godley, MD, PhD, MBA, Lead Physician Executive
Jennifer Schaulin, Pediatric Practice Leader
c/o Charlotte Tinsley, Consultant
Executive & Physician Leadership Search, AMN Healthcare